Quick Answer
ProMIS Neurosciences Inc. reported Operating Income Loss of -$40.17 million for the year ending 2025.
- ProMIS Neurosciences Inc. showed a decrease of -138.7% in Operating Income Loss from 2024 to 2025.
- This data is from ProMIS Neurosciences Inc.'s annual report (Form 10-K), filed with the SEC on March 25, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 5 years of available data (2021 to 2025), ProMIS Neurosciences Inc.'s Operating Income Loss has declined by 384.5%.
- Historical annual values: Fiscal year 2025: -$40.17 million | Fiscal year 2024: -$16.83 million | Fiscal year 2023: -$14.26 million | Fiscal year 2022: -$23.38 million | Fiscal year 2021: -$8.29 million.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: